Pharmaceutical Stability of Brands of Paracetamol Tablets under Different Environmental Conditions

doi.org/10.26538/tjnpr/v3i5.1

Authors

  • Olutayo A. Adeleye Department of Pharmaceutics and Pharmaceutical Technology, Olabisi Onabanjo University, Ago Iwoye, Ogun State, Nigeria.
  • John O. Ayorinde Department of Pharmaceutics and Industrial Pharmacy, University of Ibadan, Ibadan, Oyo State, Nigeria.
  • Lateef G. Bakre Department of Pharmaceutics and Pharmaceutical Technology, Olabisi Onabanjo University, Ago Iwoye, Ogun State, Nigeria.
  • Oluwayemisi A. Bamiro Department of Pharmaceutics and Pharmaceutical Technology, Olabisi Onabanjo University, Ago Iwoye, Ogun State, Nigeria.

Keywords:

paracetamol, drug content, degradation, environmental conditions, Stability

Abstract

Drugs are exposed to some conditions which are inevitable in the shelf-life of those drugs. Such conditions are met during drug distribution to the point of consumption. If stability of a drug product is not maintained throughout its shelf-life, quality, safety, potency and efficacy will be compromised. This study aimed to investigate the effect of these conditions on the pharmaceutical stability of paracetamol tablet formulations. Three brands of paracetamol tablets were stored in their original packages under different environmental conditions (living room, kitchen, out-door and trunk of a car) for 24 months. Samples were withdrawn at different time intervals and evaluated for variations in weight, diameter, hardness, friability, content uniformity and disnegration and dissolution. One-way ANOVA and student t-test were used to compare difference in data. Organoleptic properties of the tablets were maintained for the 24 months except the brands kept out-door which had an off white colouration. Drug degradation was minimal with the paracetamol packaged in PVC blisters. The pharmaceutical stability of the three products in the living room and in the kitchen at 24 months was not adversely affected while those kept out- door and in the trunk of a saloon car was adversely affected.

References

Sultana S and Mohammed S. A review on stability studies of pharmaceutical products. Int J Pharma Res Sch. 2018; 7(11):28-49.

Putcha L, Berens KL, Marshburn TH, Ortega HJ, Billica RD. Pharmaceutical use by U.S. astronauts on space shuttle missions. Aviat Space Environ Med. 1999; 70(7):705-708.

Brian Du, Daniels VR, Vaksman Z, Boyd JL, Crady C, Putcha L. Evaluation of physical and chemical changes in pharmaceuticals flown on space missions. AAPS J. 2011; 13(2):299–308.

Guo Y. Impact of solid-state characteristics to the physical stability of drug substance and drug product. In: Huynh-Ba K (Ed). Handbook of stability testing in pharmaceutical development: regulations, methodologies, and best practices. New York: Springer Science + Business Media; 2009. 241– 261 p.

Albert V, Lanz M, Imanidis I, Hersberger KE, Arnet I. Stability of medicines after repackaging into multicompartment compliance aids: eight criteria for detection of visual alteration. Drugs & Ther Persp. 2017; 33 (10):487-496.

Lucas T, Bishara R, Seevers RH. A stability program for the distribution of drug products. Pharm Technol. 2004; 2:68-73.

Langner MD and Maibach HI. Many common drugs in dermatology are light, temperature, or moisture-sensitive. Skin Ther Lett. 2009; 14(1):3-5.

Carter SJ. Tutorial Pharmacy, C.B.S. Publishers, India; 1986. 68-69 p.

Martins A, Swarbrick J, Cammarata A. Physical Pharmacy, Lea and Febiger, Philadelphia; 1983. 386-389 p.

Venkataraman S and Manasa M. Forced degradation studies: Regulatory guidance, characterization of drugs, and their degradation products - a review. DIT 2018; 10 (2):137-146.

Troy DB. Remington: The science and Practice of Pharmacy. 21st Ed. Philadelphia: Lippincott, Williams & Wilkins, 2006. 2393p.

Bakre LG and Yusuf T. Studies of the effect of storage conditions on some pharmaceutical parameters of powders and tablets. Dhaka Univ J Pharm Sci. 2015; 14(2):147-151.

Aulton ME. Aulton's Pharmaceutics. The Design and Manufacture of Medicines, ISBN 978-0-443-10108-3, Edinburgh, Churchill Livingstone; 2007.

Panainte A, Popa G, Vieriu M. Evaluation of qualitative and quantitative stability parameters of a new tablet formulation containing bisoprolol fumarate. Farmacia. 2018; 66(3):487- 493.

Albert V, Lanz M, Imanidis I, Hersberger KE, Arnet I. Stability of medicines after repackaging into multicompartment compliance aids: eight criteria for detection of visual alteration. Drugs & Ther Persp. 2017; 33(10):487-496.

Sanjay B, Dinesh S, Neha S. Stability testing of pharmaceutical products. J App Pharm Sci. 2012; 02(03):129- 138.

WHO. Stability testing of active pharmaceutical ingredients and finished pharmaceutical products In: WHO Expert Committee on Specifications for Pharmaceutical Preparations: fifty second report. Geneva: World Health Organization; 2018: Annex 10 (WHO Technical Report Series, No. 1010).

The United States Pharmacopeia and National Formulary USP 32–NF 27; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2009.

Bele MH. Pharmaceutics formulation and processing of conventional dosage form. First Edition. Carrer Publication; 2012. 48-55, 128-131 p.

Kalia A, Khurana S, Bedi N. Formulation and evaluation of mouth dissolving tablet of oxcarbazepine. Int J Pharm Pharm Sci. 2009; 1(1):12-23.

Adeleye OA, Femi-Oyewo MN, Odeniyi MA. Effect of compression pressure on mechanical and release properties of tramadol matrix tablets. Curr Issues in Pharm Med Sci. 2015; 28(2):120-125.

Jain C and Naruka P. Formulation and evaluation of fast dissolving tablet of valsartan. Int J Pharm Pharm Sci 2009; 1:219-226.

Gandhi A. Mouth dissolving tablet: a new venue in modern formulation tech. Pharma Innov. 2012; 1:16-21.

Adeoye O and Alebiowu G. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet. Acta Pol Pharm. 2014; 71(5):803-811.

Giri TK, Barwey N, Verma S, Alexander A, Badwaik AH, Tripathi DK. Comparative assessment of the quality measurement of some commercially available paracetamol tablets. Int J Pharm Sci Rev Res. 2012; 14(2):42-46.

Obitte1 NC, Chukwu A, Odimegwu DC, Nwoke VC. Survey of drug storage practice in homes, hospitals and patent medicine stores in Nsukka. Nig Sci Res and Essay 2009; 4(11):1354-1359.

Azila-Gbettor EM, Atatsi EA, Adigbo ED. Hawking of medicinal drugs: The perspective of the Ghanaian consumer. Res Hum Soc Sci. 2014; 4(11):37-43.

Abubakar K, Biambo AA, Samaila A, Usman N, Abubakar SB, Muhammad A. Factors responsible for proliferation of drug hawking in Sokoto Metropolis, North Western Nigeria. Basic Res J Med Clin Sci. 2015; 4(4):151-155.

Jassim A. In-home drug storage and self-medication with antimicrobial drugs in Basrah, Iraq. Oman Med J. 2010; 25:79-87.

Tsiligianni IG, Delgatty C, Alegakis A, Christos LC. A household survey on the extent of home medication storage. A cross-sectional study from rural Crete, Greece. Euro J Gen Prac. 2012; 18(1):3-8.

Pankajkumar PD, Chacko S, Prakashkumar BS. Storage and disposal of medicines in home - A review. J Pharm Res. 2016; 10(5):290-295.

Pavlovska G and Tanevska S. Influence of temperature and humidity on the degradation process of ascorbic acid in vitamin C chewable tablets. J Therm Anal Calorim. 2013; 111(3): 1-10.

Ahmad I, Shaikh RH. Effect of temperature and humidity on hardness and friability of packaged Paracetamol tablet formulations. Pak J Pharm Sci. 1994; 7(2):69-78.

Monika T, Kumar SA, Raj SA. Effect of moisture content of exicipient (microcrystalline cellulose) on direct compressible solid dosage forms. Int J Pharm Sci Res. 2017; 8(1):282-288.

Anbarasan A, Nataraj J, Shanmukhan N, Radhakrishnan A. Effect of hygroscopicity on pharmaceutical ingredients, methods to determine and overcome: An overview. J Chem Pharm Res. 2018; 10(3):61-67.

Olusanmi CW, Ghadiri M, Ding Y, Roberts KJ. Effect of temperature and humidity on the breakage behaviour of aspirin and sucrose particles. Powder Technol. 2010; 201(3): 248–252.

Moncmanová A. Environmental factors that influence the deterioration of materials. WIT Transactions on State of the Art in Science and Engineering 2007; 28.

Mubengayi K, Karbane ME, Mpona-minga M, Cherrah Y, Essassi EM, Ramli Y. Quality evaluation of acetaminophen formulations manufactured in Congo DR . J Chem Pharm Res. 2013; 5(7):21-27.

Haywood A, Mangan M, Glass B. Stability implications of repackaging paracetamol tablets into dose administration aids. J Pharm Pract Res. 2006; 36:25-28.

Tsvetkova BG, Kostova BD, Rachev DR, Peikova LP, Pencheva IP. HPLC assay and stability studies of tablets containing paracetamol and caffeine. Int J Pharm Sci Rev Res. 2013; 18(1):138-142.

Muti H and Othman S. Effects of binders and moisture content on the disintegration, hardness and friability of paracetamol and orphenadrine citrate. Drug Dev Ind Pharm. 1989; 15(12):2017-2035.

Raman B, Morrissey H, Ball P. Pharmaceuticals in the tropics: A quantitative study measuring changes in quantity of the active ingredient and microbiological growth. J App Pharm Sci. 2017; 7 (09):160-170.

EL-Hosary R, EL-Wazzan VS, Hassan ES. Safety of splitting some paracetamol tablets in Egyptian market for children administration: A quality control overview. J Drug Res. 2016; 37(1):83-94.

Gilpin RK and Zhou W. Studies of the thermal degradation of acetaminophen using a conventional HPLC approach and electrospray ionization-mass spectrometry. J Chromatogr Sci. 2004; 42(1): 15-20.

Downloads

Published

2019-05-01

How to Cite

Adeleye, O. A., Ayorinde, J. O., Bakre, L. G., & Bamiro, O. A. (2019). Pharmaceutical Stability of Brands of Paracetamol Tablets under Different Environmental Conditions: doi.org/10.26538/tjnpr/v3i5.1. Tropical Journal of Natural Product Research (TJNPR), 3(5), 149–154. Retrieved from https://www.tjnpr.org/index.php/home/article/view/1697